Enteric medicinal composition for treating diabetes and preparation method thereof

A composition and anti-diabetic technology, which can be used in drug combinations, pharmaceutical formulas, sugar-coated pills, etc., can solve the problems of gastric irritation of the main drug, achieve uniform drug release, good quality controllability, and reduce individual differences
CN101190179AActive Publication Date: 2008-06-04北京利龄恒泰药业有限公司
2 Cites 22 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
北京利龄恒泰药业有限公司
Publication Date
2008-06-04

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The invention discloses a biguanide anti-diabetes medicine, in particular to a metformin hydrochloride enteric-coated medicine compound. The medicine compound is provided with a. a hollow pill core; b. a biguanide anti-diabetes medicine active component layer which is covered outside the hollow pill core; c. an enteric-coated layer which is covered outside the biguanide anti-diabetes medicine active component layer. The invention also discloses a method of preparing the medicine compound.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a pharmaceutical composition for treating diabetes and a preparation method thereof. In particular, it relates to a biguanide drug, especially an enteric-coated pharmaceutical composition of metformin hydrochloride and a preparation method thereof. Background technique

[0002] Diabetes is a common endocrine disease. It is the third disease with the highest disability rate and fatality rate after cardiovascular disease and cancer. It has seriously endangered human health. Oral drugs for the treatment of type 2 diabetes are mainly divided into four categories, namely sulfonylureas, biguanides, α-glucosidase inhibitors and insulin sensitizers. The hypoglycemic effect of biguanide drugs is due to inhibiting the uptake of glucose by intestinal wall cells, promoting glycolysis and inhibiting hepatic gluconeogenesis, which will not cause hypoglycemia, and are widely used clinically. Such drugs include benzene Among phenformin, metf...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More